


Intelligent OMICS Revenue
Pharmaceutical Manufacturing • Nottingham, England, United Kingdom • 1-10 Employees
Intelligent OMICS revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at Intelligent OMICS
Simon Haworth
Director
Company overview
| Headquarters | Biocity, Pennyfoot Street, Nottingham, Notts NG1 1GF, GB |
| Phone number | +441462742435 |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Diabetes, Sepsis, China, Data Mining, Drug Discovery, Alzheimer'S, Artificial Intelligence, Tuberculosis, Systems Biology, Computational Biology, Lung Cancer, Network Biology, Molecular Discovery, Auto-Immune Disease, Diagnostic Discovery |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
Intelligent OMICS Email Formats
Intelligent OMICS uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@intellomx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@intellomx.com | 100% |
About Intelligent OMICS
Intelligent OMICS Ltd (Intellomx) is a UK-based AI company that discovers new drugs. We use proprietary technology to identify the biological targets that research has missed and we then progress drug development from idea to IND. We collaborate with others via fee-for-service projects but we also practice what we preach, applying our own technology in-house. We currently seek partners for our lung cancer/KRAS drugs, identified using our own technology. Contact us if we can help you discover drugs for your pipeline too. Technology: Our systems approach is called "Intuitive Informed Intelligence". Our technology approach is based on high speed creation of Artificial Neural Networks (ANNs) which can evaluate tens of millions of data in short period of time, to identity key drivers for systems biology. And to connect these drives to therapeutic modalities including new drugs, repurposed drugs and biomarker panels for disease. Intellomx uses novel proprietary Artificial Intelligence approaches applied to translational biology to discover new drugs for old diseases identify existing drugs for new targets create new diagnostics to stratify patient populations We transform biological data into clinical benefit! Come join the AI-driven drug discovery revolution.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Intelligent OMICS has never raised funding before.
Intelligent OMICS Tech Stack
Discover the technologies and tools that power Intelligent OMICS's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Performance
Frequently asked questions
4.8
40,000 users



